Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Atherosclerosis Progression in HIV-positive Patients
NCT00673582Phase 4Terminated
- Sponsor
- University of British Columbia
- Start
- Apr 2008
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in atherosclerosis, sponsored by University of British Columbia. Started Apr 2008; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00673582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673582.